USPTO serial 79276584
TYRION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2020
- Examiner
- DOMBROW, COLLEEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with TYRION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial and scientific chemicals, namely, chemicals for use in industry and science; biological preparations for use in industry and science, including conjugates, polypeptide conjugates, immunoconjugates of antibodies and antibody derivatives | ACTIVE | — |
| 005 | Pharmaceutical products for the prevention and treatment of cardiovascular diseases of the central nervous system; pharmaceutical products for treatment of cancer, thrombosis and respiratory diseases; pharmaceutical preparations for treatment of rare diseases, namely, lysosomal storage diseases and rare blood disorders; pharmaceutical products for prevention and treatment of infectious diseases; pharmaceutical products for treatment of immuno-inflammatory diseases | ACTIVE | — |
| 042 | Scientific research and laboratory research services in the field of biotechnology; biotechnology research; consulting in the field of biotechnology, bacteriological research, biological research; research and development of new pharmaceuticals for third parties; conducting clinical trials for others; chemical research and analysis services, medical research, pharmaceutical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 17, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 10, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 18, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 17, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 1, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 7, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 28, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 28, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 28, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 28, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 23, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |